NorthWest Biotherapeutics Inc (NWBO)

[newman2021]

yes, because the publication cannot take this long in my view. What we got is a unique trial based on dendritic cell immunotherapy and the world wants to know how it did. Getting it published in a 2400 words article should not take this long because every high pitched journal would want to publish the results in their journal. The delay is much more related to the regulatory approval in my opinion. We still got plenty of time to hit the March and April tote bag time frame, imo.